Another study (16) reported that chidamide inhibited the viability of myelodysplastic syndrome and AML cells by suppressing JAK2/STAT3 signaling or inducing apoptosis via the accumulation of DNA damage and repair defects in AML stem and progenitor cells. Here, STAT3 is linked to myelodysplastic syndrome.